{"protocolSection":{"identificationModule":{"nctId":"NCT01092819","orgStudyIdInfo":{"id":"CLP 2988.B"},"organization":{"fullName":"Penumbra Inc.","class":"INDUSTRY"},"briefTitle":"A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial","officialTitle":"Functional Outcome and Recovery After STROKE: The FIRST Trial","acronym":"FIRST"},"statusModule":{"statusVerifiedDate":"2019-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-12"},"primaryCompletionDateStruct":{"date":"2013-12","type":"ACTUAL"},"completionDateStruct":{"date":"2013-12","type":"ACTUAL"},"studyFirstSubmitDate":"2010-03-23","studyFirstSubmitQcDate":"2010-03-24","studyFirstPostDateStruct":{"date":"2010-03-25","type":"ESTIMATED"},"lastUpdateSubmitDate":"2019-04-10","lastUpdatePostDateStruct":{"date":"2019-04-12","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Penumbra Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"Current literature has only limited information on the natural history of acute ischemic stroke from large vessel occlusion in a stroke cohort who presents within 8 hours from symptom onset, particularly on 90 day functional outcome as defined by the mRS. Data from this trial will advance our knowledge on this important topic and may serve as a bench mark for future trials"},"conditionsModule":{"conditions":["Stroke"],"keywords":["acute ischemic stroke, large vessel occlusion, natural history, functional outcome"]},"designModule":{"studyType":"OBSERVATIONAL","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":150,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"acute ischemic stroke","description":"Patients presenting with symptoms of acute ischemic stroke within 8 hours from symptom onset and with an imaging-defined large cerebral vessel occlusion.","interventionNames":["Other: Current standard of care for acute ischemic stroke other than IV rtPA or other IA therapies"]}],"interventions":[{"type":"OTHER","name":"Current standard of care for acute ischemic stroke other than IV rtPA or other IA therapies","description":"The objective of this study is to determine the natural history of acute ischemic stroke from large vessel thromboembolism in the brain. Patients with current standard of care other than IV rtPA or IA therapies will be studied.","armGroupLabels":["acute ischemic stroke"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Functional outcome at 90 days after presentation as defined by a modified Rankin Score of 0-2.","timeFrame":"90 days after presentation"}],"secondaryOutcomes":[{"measure":"â€¢ Good neurological recovery as defined by a NIHSS score of 0-1 at discharge or a 10-point or more improvement in this scale at discharge.","timeFrame":"Discharge and 90 days after presentation"},{"measure":"All cause mortality","timeFrame":"Dishcharge and 90 days after presentation"},{"measure":"Incidence of symptomatic and asymptomatic hemorrhage","timeFrame":"Dishcharge and 90 days after presentation"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* From 18 to 85 years of age.\n* Evidence of proximal anterior circulation large vessel occlusion (TIMI 0-1)(TICI 0-1) from CT Angiography. Target vessel occlusion may include the anterior circulation.\n* Presented with symptoms consistent with acute ischemic stroke within 8 hours of symptom onset. Patients who presented within 3 hours must be ineligible or refractory to IV rtPA therapy.\n* At time of enrollment, neurological deficit resulting in an NIH Stroke Scale (NIHSS) score greater than 10\n* Known core infarct volume assessed by CTP, CTA or DWI scans\n\nExclusion Criteria:\n\n* History of stroke in the past 3 months.\n* Pre-existing neurological or psychiatric disease that could confound the study results such as a pre-stroke mRS score greater than 1\n* Known severe allergy to contrast media\n* Uncontrolled hypertension (defined as systolic blood pressure greater than 185 mmHg or diastolic blood pressure less than 110 mmHg)\n* CT evidence of the following conditions before enrollment:\n\n  * Significant mass effect with midline shift\n  * Evidence of intracranial hemorrhage\n* Treated with endovascular therapy for acute stroke\n* Life expectancy less than 90 days\n* Participation in another clinical investigation that could confound the evaluation of the study","healthyVolunteers":false,"sex":"MALE","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients presenting with symptoms of acute ischemic stroke within 8 hours from symptom onset and with an imaging-defined large cerebral vessel occlusion and a known infarct volume will be enrolled and followed for 90-days.","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Siu Po Sit, PhD","affiliation":"Penumbra Inc.","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Texas Stroke Institute","city":"Plano","state":"Texas","zip":"75075","country":"United States","geoPoint":{"lat":33.01984,"lon":-96.69889}},{"facility":"Queen Mary Hospital","city":"Hong Kong","state":"Hong Kong","country":"China","geoPoint":{"lat":22.39407,"lon":114.13737}},{"facility":"The Prince of Wales Hospital","city":"Shatin","state":"Hong Kong","country":"China"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M13539","name":"Tissue Plasminogen Activator","relevance":"LOW"}],"browseBranches":[{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}